Pfizer chairman talks about how they will impact cancer patients

Pfizer's chairman and CEO, Albert Bourla, stated regarding the acquisition of Seagen and its focus on oncology, "Seagen acquisition and oncology.

It is what it is - our new Covid.

I think will be blockbuster drugs... they will have significant impact on cancer patients."